Hematology

Hematology

Dr. Joshua Brody, MD, in front of New York City skyline, discussing Liso-Cel treatment for relapsed DLBCL patients.

Hematology

07/02/2026

Liso-Cel in Relapsed DLBCL: Patient Selection, Outcomes, and Referral Strategies

Joshua Brody, MD

Two medical professionals, Sawyer Bawek and Agrima Mian, discuss lymphoma data at ASCO 2026, with a city skyline background.

Hematology

06/26/2026

ASCO 2026: Key Lymphoma Data From the frontMIND and SUNMO Trials

Sawyer Bawek, DOAgrima Mian, MD

Two medical professionals discussing Talquetamab monitoring and management strategies in an urban park setting.

Hematology

06/20/2026

Talquetamab Side Effects: Management and Counseling Strategies

Sawyer Bawek, DOHamza Hashmi, MD

Two medical professionals, Sawyer Bawek and Hamza Hashmi, discuss Teclistamab in earlier treatment lines for multiple myeloma with a city skyline background.

Hematology

06/17/2026

MajesTEC-9 Data and Teclistamab in Earlier Treatment Lines for Multiple Myeloma

Sawyer Bawek, DOHamza Hashmi, MD

Two medical professionals, Sawyer Bawek DO and Hamza Hashmi MD, discuss the evolution of CAR T-cell therapy against a cityscape background.

Hematology

06/16/2026

The Growing Role of CAR T-Cell Therapies in Multiple Myeloma

Sawyer Bawek, DOHamza Hashmi, MD

Image showing the ASCO 2026 conference banner with the study title on a city skyline background, highlighting advancements in multiple myeloma treatment.

Hematology

06/16/2026

ASCO 2026: Mezigdomide Plus Kd Doubles PFS in Heavily Pretreated Multiple Myeloma in SUCCESSOR-2

Sawyer Bawek, DO